Gamble Jones Investment Counsel Abbott Laboratories Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Abbott Laboratories stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 218,626 shares of ABT stock, worth $25.3 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares

218,626

Previous 219,685 0.48%

Holding current value

$25.3 Million

Previous $21.3 Million 12.94%

% of portfolio

1.81%

Previous 1.73%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $100,668 - $118,099	-1,059 Reduced 0.48%	218,626 $24 Million
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $344,852 - $399,274	-3,564 Reduced 1.6%	219,685 $21.3 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $825,950 - $998,310	-8,092 Reduced 3.5%	223,249 $24.3 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $87,225 - $106,365	-765 Reduced 0.33%	231,341 $27.4 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $70,819 - $86,714	-613 Reduced 0.26%	232,106 $32.7 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $145,475 - $160,937	-1,247 Reduced 0.53%	232,719 $27.5 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $129,698 - $152,673	-1,226 Reduced 0.52%	233,966 $27.1 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $12,298 - $14,489	-113 Reduced 0.05%	235,192 $28.2 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $2.52 Million - $2.75 Million	-23,998 Reduced 9.25%	235,305 $25.8 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $268,321 - $325,857	-2,928 Reduced 1.12%	259,303 $28.2 Million
Q2 2020 Aug 19, 2020	BUY	$76.57 - $98.0 $6,661 - $8,526	87 Added 0.03%	262,231 $24 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $275,654 - $403,081	4,388 Added 1.7%	262,144 $20.7 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $188,895 - $210,284	2,406 Added 0.94%	257,756 $22.4 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $171,045 - $185,466	-2,090 Reduced 0.81%	255,350 $21.4 Million
Q2 2019 Aug 20, 2019	SELL	$72.88 - $85.0 $594,919 - $693,855	-8,163 Reduced 3.07%	257,440 $21.7 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $28,275 - $34,185	-427 Reduced 0.16%	265,603 $21.2 Million
Q4 2018 Feb 04, 2019	SELL	$65.56 - $74.27 $217,462 - $246,353	-3,317 Reduced 1.23%	266,030 $19.2 Million
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $253,820 - $306,204	-4,174 Reduced 1.53%	269,347 $19.8 Million
Q2 2018 Aug 03, 2018	SELL	$57.57 - $63.54 $111,282 - $122,822	-1,933 Reduced 0.7%	273,521 $16.7 Million
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $393,383 - $444,767	-6,991 Reduced 2.48%	275,454 $16.5 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $1.99 Million - $2.13 Million	-37,129 Reduced 11.62%	282,445 $16.1 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $15.4 Million - $17.1 Million	319,574	319,574 $17.1 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Abbott Laboratories Transaction History